Shin Kong Hospital emerges as unexpected winner in Taishin-Shin Kong merger

The long-standing financial holding battle among the Shin Kong family brothers has concluded with the merger of Taishin and Shin Kong Financial Holdings, rebranded as Taishin-Shin Kong Financial Holding in 2025. While elder brother Wu Dong-jin relinquished management control, his affiliated Shin Kong Hospital has emerged as a significant, albeit unexpected, winner from the consolidation.

The merger has substantially boosted the value of Shin Kong Hospital's holdings in the financial group. Its book value for shares in the financial holding company has surged by NT$3.4 billion. Furthermore, the hospital's cash dividend income has nearly tripled, providing a substantial financial windfall.

Shin Kong Hospital has a history of holding significant stakes in its parent financial group's companies, a strategy used to solidify management control through cross-shareholding. As of the end of 2023, the book value of its holdings in Shin Kong Financial Holding was approximately NT$5.276 billion. By the end of 2024, with a recovering market, this value rose to NT$7.215 billion.

Following the merger's effectiveness in 2025, Shin Kong Hospital's shares in Shin Kong Financial Holding were converted proportionally into common and preferred shares of the new Taishin-Shin Kong Financial Holding. This conversion pushed the book value of these holdings to over NT$8.664 billion, marking an increase of nearly NT$3.4 billion in the hospital's stock assets within three years. The hospital's actual cash earnings have also been considerable. Its "cash dividend income," listed under "non-medical revenue," was only NT$125 million in 2023 and NT$126 million in 2024. Post-merger in 2025, this figure exploded to NT$493 million, a nearly threefold increase from the previous year, driving the hospital's total investment income past the NT$500 million mark.

Unlike some peers whose core medical operations faced losses due to expansion or fluctuations in health insurance reimbursement rates, Shin Kong Hospital maintained profitability in its medical services from 2023 to 2025, with profits of NT$379 million, NT$267 million, and NT$324 million, respectively. However, the substantial cash dividends from non-medical revenue provided crucial capital for the hospital's expansion. In 2023, non-medical net profit accounted for nearly 40% of its pre-tax earnings. By 2025, with the merger, cash dividends soared to NT$493 million, contributing 70% of the hospital's total pre-tax profit for the year.